274 related articles for article (PubMed ID: 35299730)
1. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
Front Oncol; 2022; 12():846232. PubMed ID: 35299730
[TBL] [Abstract][Full Text] [Related]
2. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
Driver J; Santagata S; Bi WL; Chi JH
J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
[TBL] [Abstract][Full Text] [Related]
3. Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting
Tosefsky K; Martin KC; Rebchuk AD; Wang JZ; Nassiri F; Lum A; Zadeh G; Makarenko S; Yip S
Neurooncol Adv; 2024; 6(1):vdae002. PubMed ID: 38288091
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
6. Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas.
Shankar GM; Abedalthagafi M; Vaubel RA; Merrill PH; Nayyar N; Gill CM; Brewster R; Bi WL; Agarwalla PK; Thorner AR; Reardon DA; Al-Mefty O; Wen PY; Alexander BM; van Hummelen P; Batchelor TT; Ligon KL; Ligon AH; Meyerson M; Dunn IF; Beroukhim R; Louis DN; Perry A; Carter SL; Giannini C; Curry WT; Cahill DP; Barker FG; Brastianos PK; Santagata S
Neuro Oncol; 2017 Apr; 19(4):535-545. PubMed ID: 28170043
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?
Pfisterer WK; Hendricks WP; Scheck AC; Nieman RA; Birkner TH; Krampla WW; Preul MC
Neurosurgery; 2007 Nov; 61(5):1048-59; discussion 1060-1. PubMed ID: 18091281
[TBL] [Abstract][Full Text] [Related]
9. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Wang JZ; Patil V; Liu J; Dogan H; Tabatabai G; Yefet LS; Behling F; Hoffman E; Bunda S; Yakubov R; Kaloti R; Brandner S; Gao A; Cohen-Gadol A; Barnholtz-Sloan J; Skardelly M; Tatagiba M; Raleigh DR; Sahm F; Boutros PC; Aldape K; ; Nassiri F; Zadeh G
Acta Neuropathol; 2023 Jul; 146(1):145-162. PubMed ID: 37093270
[TBL] [Abstract][Full Text] [Related]
10. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A
AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366
[TBL] [Abstract][Full Text] [Related]
11. Discovering the Molecular Landscape of Meningioma: The Struggle to Find New Therapeutic Targets.
Maggio I; Franceschi E; Di Nunno V; Gatto L; Tosoni A; Angelini D; Bartolini S; Lodi R; Brandes AA
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679551
[TBL] [Abstract][Full Text] [Related]
12. Molecular classification and grading of meningioma.
Nasrallah MP; Aldape KD
J Neurooncol; 2023 Jan; 161(2):373-381. PubMed ID: 36802047
[TBL] [Abstract][Full Text] [Related]
13. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
14. Advances in Molecular Biological and Translational Studies in World Health Organization Grades 2 and 3 Meningiomas: A Literature Review.
Okano A; Miyawaki S; Teranishi Y; Ohara K; Hongo H; Sakai Y; Ishigami D; Nakatomi H; Saito N
Neurol Med Chir (Tokyo); 2022 Aug; 62(8):347-360. PubMed ID: 35871574
[TBL] [Abstract][Full Text] [Related]
15. Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Biczok A; Thorsteinsdottir J; Karschnia P; Ruf VC; Tonn JC; Herms J; Schichor C; Dorostkar MM
Acta Neuropathol Commun; 2023 Jan; 11(1):12. PubMed ID: 36641486
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic dysregulation in meningiomas.
Wedemeyer MA; Muskens I; Strickland BA; Aurelio O; Martirosian V; Wiemels JL; Weisenberger DJ; Wang K; Mukerjee D; Rhie SK; Zada G
Neurooncol Adv; 2022; 4(1):vdac084. PubMed ID: 35769412
[TBL] [Abstract][Full Text] [Related]
17. High-grade meningiomas: biology and implications.
Bi WL; Prabhu VC; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
[TBL] [Abstract][Full Text] [Related]
18. Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated.
Maas SLN; Stichel D; Hielscher T; Sievers P; Berghoff AS; Schrimpf D; Sill M; Euskirchen P; Blume C; Patel A; Dogan H; Reuss D; Dohmen H; Stein M; Reinhardt A; Suwala AK; Wefers AK; Baumgarten P; Ricklefs F; Rushing EJ; Bewerunge-Hudler M; Ketter R; Schittenhelm J; Jaunmuktane Z; Leu S; Greenway FEA; Bridges LR; Jones T; Grady C; Serrano J; Golfinos J; Sen C; Mawrin C; Jungk C; Hänggi D; Westphal M; Lamszus K; Etminan N; Jungwirth G; Herold-Mende C; Unterberg A; Harter PN; Wirsching HG; Neidert MC; Ratliff M; Platten M; Snuderl M; Aldape KD; Brandner S; Hench J; Frank S; Pfister SM; Jones DTW; Reifenberger G; Acker T; Wick W; Weller M; Preusser M; von Deimling A; Sahm F;
J Clin Oncol; 2021 Dec; 39(34):3839-3852. PubMed ID: 34618539
[TBL] [Abstract][Full Text] [Related]
19. Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical Outcome.
Marastoni E; Barresi V
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296907
[TBL] [Abstract][Full Text] [Related]
20. WHO grade and pathological markers of meningiomas: Clinical and prognostic role.
Franca RA; Della Monica R; Corvino S; Chiariotti L; Del Basso De Caro M
Pathol Res Pract; 2023 Mar; 243():154340. PubMed ID: 36738518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
